HTFL
$26.02+0.13 (+0.50%)
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide.
Recent News
HeartFlow Inc (HTFL) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
HeartFlow Inc (HTFL) reports a 40% revenue increase and unveils new AI-driven tools, setting the stage for continued expansion and competitive advantage.
Heartflow Q4 Earnings Call Highlights
Heartflow (NASDAQ:HTFL) executives highlighted record revenue, accelerating adoption of its platform, and expanding reimbursement support during the company’s fourth-quarter 2025 earnings call, while also initiating 2026 guidance and outlining product and clinical milestones expected over the next y
HeartFlow: Q4 Earnings Snapshot
The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share. The medical technology company posted revenue of $49.1 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $46.6 million.
What Makes Heartflow (HTFL) an AI Beneficiary?
Baron Capital, an investment Management Company, released its fourth quarter 2025 investor letter for its “Baron Opportunity Fund”. A copy of the letter can be downloaded here. The Fund returned 4.63% (Institutional Shares) in Q4 2025, outperforming the Russell 3000 Growth Index’s (the Benchmark) 1.14% gain and the S&P 500 Index’s 2.66% return. The Fund […]
Earnings To Watch: HeartFlow Inc (HTFL) Reports Q4 2025 Result
This article first appeared on GuruFocus. HeartFlow Inc (NASDAQ:HTFL) is set to release its Q4 2025 earnings on Mar 18, 2026. The consensus estimate for Q4 2025 revenue is $46.50 million, and the earnings are expected to come in at -$0.27 per share.